Similar findings emerged with the PERK activator (SB202190) in neuroblastoma cells, where activated PERK led to an increase in cytosolic Ca2+ levels that subsequently promoted the translocation of TEFB into the nucleus via the calcineurin-dependent dephosphorylation of TFEB. Here, EIF2AK3 is linked to neuroblastoma.